ELEVAI Skincare

The Science of Skincare

Founded by a team of renowned scientists and medical professionals, ELEVAI is poised to shift the skincare paradigm by delivering advanced and innovative skincare products that promise to elevate the condition of your skin.

Blockquote Icon

Our Mission

To solve the unmet needs in the regenerative aesthetics space through a combination of cutting-edge science, design, and clinical expertise.

ELEVAI Skincare Logo

Post-Treatment E Series

Prescription-strength skin care systems for the physician-dispensed market.

Proprietary formulation technology perfected by extensive data and by cutting-edge science to enhance the results of in-office procedures such as micro-needling, laser resurfacing, microdermabrasion, and chemical peels. ELEVAI products are formulated in our own lab in the USA. Supported by previous and on-going stem cell research, our ultimate products will address the core of the problem and improve your skin more effectively than any other products on the market.

ELEVAI Skincare Logo


The After-Treatment

A clean, concentrated serum with a high amount of potent ELEVAI exosomes with preservative specifically designed for one-time application post procedures. Powerful and gentle to help skin recover and with anti-inflammatory effects for boosted healing. (3 mL)

ELEVAI Skincare Logo


The Continuing Care

A rejuvenating serum for at-home daily use. Effective blend of ELEVAI exosomes combined with stem cell growth factors and vitamin C that act to help with continued skin repair following office treatment. (30 mL)

Jordan R. Plews

Jordan R. Plews, PhD

Cofounder & Chief Executive Officer

Jordan R. Plews, PhD, is Cofounder & Chief Executive Officer of ELEVAI Skincare.  He has had leading roles in building teams, consulting, and advising on clinical development programs and product launches at various pharmaceutical companies including Pfizer, where he led the bioprocess development group and worked on skin cancer treatments and biologics.

Dr. Plews, whose research has been published in top tier medical journals such as Nature Methods and the Journal of Cellular and  Molecular Medicine, obtained his postdoctoral training at Stanford University.  There, he conducted research and trained Ph.D. students.  Following many years of research utilizing various types of stem cells to treat a variety of health issues, Dr. Plews co-founded Xytogen Biotech in 2015, a California based cosmeceutical company developing next-generation topical, stem cell based skincare solutions.  Over a five-year period, he led a team to build a fully-functioning stem cell culture laboratory, and launch over five high-end products that generated multi-million dollars in top line national sales.

Dr. Plews’ career spans biochemical engineering, molecular biology, and stem cell applications. He earned a Ph.D. from and received first class honors in the engineering doctorate program in Biochemical Engineering & Bioprocess Management at University College London.

Tim Sayed

Tim Sayed, MD, MBA, FACS

Cofounder & Chief Medical Officer

Tim Sayed, MD, MBA, FACS is Cofounder and Chief Medical Officer of ELEVAI Skincare.  Dr. Sayed is a double board-certified plastic surgeon with nearly two decades of experience who practices in Southern California.  Presently, he owns and operates plastic surgery offices in Southern California and draws patients from all around the United States and world.

Dr. Sayed has served as a medical director and investor at electronic health records and practice management company Modernizing Medicine, with over $300M in financing raised, including Warburg Pincus Series F.  He has also served as vice president and seed investor at Interpreta, which provides precision medicine clinical interpretation solutions.  Dr. Sayed has also served on the board of Fruit Street Health, which has raised over $15M from physician investors and has customer relationships with ShareCare and Walgreens.  Dr. Sayed also serves on the advisory board of Featherlink, a company which applies artificial intelligence to help improve surgical outcomes.  He also is on the advisory board at Seqster, a software-based platform to manage comprehensive electronic medical records, which has received a strategic funding from Takeda.

Dr. Sayed oversees product development, marketing and brings academic knowledge and clinical experience in aesthetics, anti-aging, skincare, and health technology. Dr. Sayed completed medical training at UCSF and surgical residency at Harvard Medical School.  He holds a B.S. in electrical engineering and computer sciences from Berkeley, M.D. from UCSF School of Medicine, and M.B.A. from the Kellogg School of Management at Northwestern University.